KING PHARMACEUTICALS, INC. FORM 424B3
Table of Contents

     
PROSPECTUS SUPPLEMENT NO. 3
  Filed Pursuant to Rule 424(b)(3) and 424(b)(7)
(To Prospectus dated June 23, 2006)
  File No. 333-135285
$400,000,000
 
LOGO
11/4% Convertible Senior Notes due 2026
and Shares of Common Stock Issuable Upon Conversion of the Notes
and Related Subsidiary Guarantees
 
     This prospectus supplement, or Supplement No. 3, supersedes and replaces the section entitled “Selling Securityholders” contained in the prospectus, dated June 23, 2006, as supplemented by Prospectus Supplement No. 1, dated July 14, 2006 and Prospectus Supplement No. 2, dated July 28, 2006, relating to the potential sale from time to time by the selling securityholders identified in this Supplement No. 3 of up to $400,000,000 aggregate principal amount of our 11/4% Convertible Senior Notes due 2026, or “Notes,” the related guarantees issued by our domestic subsidiaries and our shares of common stock issuable upon conversion of the Notes. The terms of the Notes are set forth in the prospectus dated June 23, 2006. This Supplement No. 3 is not complete without, and may not be delivered or utilized except in connection with, the prospectus dated June 23, 2006, including any amendments or further supplements thereto, except to the extent that the information in this Supplement No. 3 supersedes the information contained in the prospectus dated June 23, 2006, as supplemented by Prospectus Supplement No. 1, dated July 14, 2006 and Prospectus Supplement No. 2, dated July 28, 2006.
 
     Investing in the Notes and our common stock issuable upon conversion of the Notes involves risks that are described in the “Risk Factors” section of the accompanying prospectus beginning on page 7.
 
     NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS SUPPLEMENT OR THE PROSPECTUS, DATED JUNE 23, 2006. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus supplement is August 31, 2006.
 

 


 

TABLE OF CONTENTS
         
    Page  
Prospectus Supplement
       
    S-1  

 


Table of Contents

 
SELLING SECURITYHOLDERS
 
The Notes and subsidiary guarantees were issued and sold by us in March 2006 to Citigroup Global Markets Inc., UBS Securities LLC and Banc of America Securities LLC (the “initial purchasers”), and were re-sold by the initial purchasers pursuant to Rule 144A under the Securities Act. The selling securityholders may from time to time offer and sell pursuant to this prospectus or a supplement hereto any or all of the Notes and subsidiary guarantees listed below and the shares of common stock issued upon conversion of such Notes. When we refer to the “selling securityholders” in this prospectus or a supplement hereto, we mean those persons listed in the table below, as well as the pledgees, donees, assignees, transferees, successors and others who later hold any of the selling securityholders’ interests.
 
The table below sets forth information with respect to the selling securityholders, the principal amount of Notes and related subsidiary guarantees beneficially owned by each selling securityholder that may be offered pursuant to this prospectus or a supplement hereto and the number of shares of common stock into which such Notes are initially convertible. However, the number of shares of common stock into which such Notes are initially convertible is subject to adjustment as provided in “Description of the Notes — Conversion Rights — Conversion Rate Adjustments”; resulting from payment of any make whole amount as provided in “Description of the Notes —
Determination of the Make Whole Amount”; and resulting from any registration default as provided in “Description of the Notes — Registration Rights.” Unless set forth below, to our knowledge, none of the selling securityholders has, or within the past three years has had, any material relationship with us or any of our predecessors or affiliates or beneficially owns in excess of 1% of the outstanding common stock.
 
The principal amounts of the Notes provided in the table below are based on information provided to us by each of the selling securityholders as of August 25, 2006. Since the date on which each selling securityholder provided this information, each selling securityholder identified below may have sold, transferred or otherwise disposed of all or a portion of its Notes and subsidiary guarantees in a transaction exempt from the registration requirements of the Securities Act. Information concerning the selling securityholders may change from time to time and any changed information will be set forth in supplements or amendments to this prospectus to the extent required.
 
                                         
    Principal Amount
                         
    of Notes and
                         
    Subsidiary
    Percentage
    Number of Shares of Common Stock  
    Guarantees
    of Notes and
                Beneficially
 
    Beneficially
    Subsidiary
                Owned
 
    Owned and
    Guarantees
    Beneficially
    Offered
    After the
 
Full Legal Name of Selling Securityholder(1)
  Offered Hereby(2)     Outstanding     Owned(3)     Hereby(2)(3)     Offering(2)  
 
Allstate Insurance Company(4)
  $ 2,000,000       *       183,539       96,006       87,533  
Aristeia International Limited
    22,240,000       5.6 %     1,067,588       1,067,588       0  
Aristeia Partners LP
    2,760,000       *       132,488       132,488       0  
Black Diamond Convertible Offshore LOC
    2,000,000       *       96,006       96,006       0  
Black Diamond Offshore, Ltd. 
    1,127,000       *       54,099       54,099       0  
Calamos Convertible Fund — Calamos Investment Trust
    4,650,000       1.2 %     223,214       223,214       0  
Calyon S/A 
    6,000,000       1.5 %     288,018       288,018       0  
Canyon Capital Arbitrage Master Fund Ltd. 
    8,250,000       2.1 %     459,389       396,025       63,364 (8)  
Canyon Value Realization Fund, L.P. 
    4,250,000       1.1 %     236,655       204,013       32,642 (8)  
The Canyon Value Realization Fund (Cayman), Ltd. 
    11,250,000       2.8 %     630,279       540,034       90,245 (8)  
Canyon Value Realization MAC 18, Ltd. (RMF) 
    1,250,000       *     65,763       60,003       5,760 (8)  
Citidel Equity Fund Ltd. 
    86,500,000       21.6 %     4,152,268       4,152,268       0  
CNH CA Master Account, L.P. 
    10,000,000       2.5 %     480,031       480,031       0  
CQS Convertible and Quantitative Strategies Master Fund Limited
    40,000,000       10.0 %     1,920,124       1,920,124       0  
DBAG London
    15,193,000       3.8 %     729,311       729,311       0  
D. E. Shaw Valance Portfolios L.L.C
    38,500,000       9.6 %     1,848,119       1,848,119       0  
Deutsche Bank Securities Inc. 
    1,000,000       *       48,003       48,003       0  
Double Black Diamond Offshore LOC
    6,873,000       1.7 %     329,925       329,925       0  
Fore Convertible Master Fund, Ltd. 
    18,254,000       4.6 %     876,248       876,248       0  
Fore Erisa Fund, Ltd. 
    1,746,000       *       83,813       83,813       0  
Fore Multi Strategy Master Fund, Ltd. 
    5,092,000       1.3 %     244,431       244,431       0  
Highbridge International LLC
    5,000,000       1.3 %     240,015       240,015       0  


S-1


Table of Contents

                                         
    Principal Amount
                         
    of Notes and
                         
    Subsidiary
    Percentage
    Number of Shares of Common Stock  
    Guarantees
    of Notes and
                Beneficially
 
    Beneficially
    Subsidiary
                Owned
 
    Owned and
    Guarantees
    Beneficially
    Offered
    After the
 
Full Legal Name of Selling Securityholder(1)
  Offered Hereby(2)     Outstanding     Owned(3)     Hereby(2)(3)     Offering(2)  
 
KBC Financial Products (Cayman Islands) Ltd. 
    15,500,000       3.9 %     744,048       744,048       0  
KBC Financial Products USA Inc. 
    8,500,000       2.1 %     408,026       408,026       0  
LDG Limited
    588,000       *     28,225       28,225       0  
Lydian Global Opportunities Master Fund Ltd. 
    5,000,000       1.3 %     240,015       240,015       0  
Lydian Oversees Partners Master Fund L.P. 
    20,000,000       5.0 %     960,062       960,062       0  
Man Mac I, Ltd. 
    3,212,000       *       154,185       154,185       0  
Parabolic Partners Master Fund Ltd.
    7,000,000       1.8 %     336,021       336,021       0  
Pond Point Partners Master Fund, Ltd. 
    2,000,000       *       96,006       96,006       0  
Sandelman Partners Multi-Strategy Master Fund, Ltd.(5)
    20,000,000       5.0 %     1,677,062       960,062       717,000  
South Dakota Retirement System(6)
    2,000,000       *     167,006       96,006       71,000  
Sphinx Fund
    398,000       *     19,105       19,105       0  
Tempo Master Fund L.P. 
    10,000,000       2.5 %     480,031       480,031       0  
TQA Master Fund
    4,654,000       1.2 %     223,406       223,406       0  
TQA Master Plus Fund
    3,070,000       *     147,369       147,369       0  
Zurich Institutional Benchmark Master Fund
    1,290,000       *     61,923       61,923       0  
All other holders of Notes and subsidiary guarantees or future transferees, pledgees, donees or successors of any such holders(7)
    2,853,000       *     136,952       136,952       0  
                                         
TOTAL
  $ 400,000,000       100.0 %     20,268,768       19,201,224       1,067,544  
 
 
Less than 1%.
 
(1) Certain selling securityholders are, or are affiliates of, registered broker-dealers. These selling securityholders have represented that they acquired their securities in the ordinary course of business and, at the time of the acquisition of the securities, had no agreements or understandings, directly or indirectly, with any person to distribute the securities. To the extent that we become aware that any such selling securityholders did not acquire its securities in the ordinary course of business or did have such an agreement or understanding, we will file a post-effective amendment to the registration statement of which this prospectus is a part to designate such person as an “underwriter” within the meaning of the Securities Act of 1933.

S-2


Table of Contents

(2) We do not know when or in what amounts a selling securityholder may offer the Notes, subsidiary guarantees or shares of common stock for sale. The selling securityholder might not sell any or all of the Notes and subsidiary guarantees or shares offered by this prospectus. Because the selling securityholders may offer all or some of the Notes and subsidiary guarantees or shares pursuant to this offering, we cannot estimate the number of the Notes and subsidiary guarantees or shares that will be held by the selling securityholders after completion of the offering. However, for purposes of this table, we have assumed that, after completion of the offering, none of the Notes and subsidiary guarantees or shares covered by this prospectus will be held by the selling securityholders.
 
(3) Amounts assume conversion of all the selling securityholders’ Notes at the initial conversion rate of 48.0031 shares of common stock per $1,000 principal amount of Notes, excluding fractional shares. However, the conversion ratio, and therefore the number of shares of our common stock issuable upon conversion of the Notes, is subject to adjustment. Accordingly, the number of shares of common stock issuable upon conversion of the Notes may increase or decrease.
 
(4) Beneficial ownership includes the following additional shares of common stock which are not being offered hereby and which we have assumed will remain outstanding after the offering: 13,333 shares currently held by Allstate Insurance Company, 15,700 shares held by Agents Pension Plan and 58,000 shares of common stock held by Allstate Retirement Plan.
 
(5) Beneficial ownership includes 717,000 additional shares of common stock which are not being offered hereby and which we have assumed will remain outstanding after the offering.
 
(6) Beneficial ownership includes 71,000 additional shares of common stock which are not being offered hereby and which we have assumed will remain outstanding after the offering.
 
(7) Amounts assume that any other holders of Notes and subsidiary guarantees, or any future transferee, pledgee, donee or successor of any such other holders of Notes and subsidiary guarantees, do not beneficially own any shares of our common stock other than the shares of our common stock issuable upon conversion of the Notes. Such persons shall not be permitted to sell pursuant to the registration statement unless and until they are listed in the selling securityholders’ table in a supplement to this prospectus supplement.
 
(8) Represents shares of our common stock issuable upon conversion of Notes, at the present conversion rate, which were acquired from other selling securityholders under this prospectus and which we have assumed will remain outstanding after the offering.


S-3